Key Personnel Moves Oncocyte Corporation recently appointed Andrea James as Chief Financial Officer, presenting an opportunity for financial service providers or consulting firms to engage in discussions around financial solutions tailored to the company's growth strategy.
Product Launch Collaboration The collaboration between Oncocyte Corp. and Bio-Rad Laboratories to launch GraftAssure offers a potential avenue for partnerships with companies specializing in medical device distribution or healthcare technology integration services to enhance market penetration.
Technology Partnership Oncocyte's utilization of Bio-Rad's Droplet Digital PCR technology for transplant monitoring products indicates an opportunity for technical service providers or technology consultants to explore collaborations in implementing and optimizing such innovative solutions.
Leadership Change Impact Joshua Riggs's appointment as the Chief Executive Officer at Oncocyte presents a potential opportunity for executive coaching services or leadership development programs seeking to support the transition and strategic direction set by the new leadership.
Board of Directors Addition The addition of Louis E. Silverman as an independent member to Oncocyte's board of directors creates a chance for governance advisory firms or board consulting services to engage in discussions around governance best practices and strategic board composition.
50
$10M
51$10M$50M
501$100M$1B
34$10M
16$10M
3
38$10MOncocyte Corporation uses 8 technology products and services including Google Hosted Libraries, Twitter Emoji (Twemoji), Font Awesome, and more. Explore Oncocyte Corporation's tech stack below.
| Oncocyte Corporation Email Formats | Percentage |
| FLast@oncocyte.com | 91% |
| First.Last@oncocyte.com | 5% |
| LastFirst@oncocyte.com | 2% |
| Last@oncocyte.com | 2% |
Biotechnology ResearchCalifornia, United States51-200 Employees
Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey. For more information, visit www.oncocyte.com.
Company Overview
Media & News
Funding & FinancialsOncocyte Corporation has raised a total of $16M of funding over 5 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $16M.
Funding & FinancialsOncocyte Corporation has raised a total of $16M of funding over 5 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $16M.
1-888-653-2347 
support@leadiq.com